DAPA & AbbVie – Women’s Health Sessions – Session 2 – Thursday, June 24


  • June 24, 2021
    6:00 pm - 7:00 pm

WEBINAR 2: Thursday, June 24 – 6PM CT UTERINE FIBROIDS & Elagolix+Estradiol/NETA, indicated for heavy menstrual bleeding associated with uterine leiomyomas in pre-menopausal women Uterine fibroids, also called leiomyomas, are estrogen and progesterone-dependent non-cancerous tumors of the uterus and are the most common type of benign tumor in women of reproductive age. Traditionally, uterine fibroids Read moreDAPA & AbbVie – Women’s Health Sessions – Session 2 – Thursday, June 24

DAPA & AbbVie – Women’s Health Sessions – Session 1 – Wednesday, June 23


  • June 23, 2021
    6:00 pm - 7:00 pm

  WEBINAR 1: Wednesday, June 23, 2021 – 6PM CT  Endometriosis and Elagolix, indicated for moderate to severe endometriosis pain. One of the most common gynecologic disorders in the U.S., and affecting  roughly 10% (190 million) of reproductive age women and girls worldwide, endometriosis is a highly estrogen-dependent, chronic, inflammatory disease characterized by the growth Read moreDAPA & AbbVie – Women’s Health Sessions – Session 1 – Wednesday, June 23

May 2021 – Rhythm Pharmaceuticals – DAPA – Rare Genetic Diseases of Obesity: Challenges and Patient Cases

We're sorry, but all tickets sales have ended because the event is expired.

  • May 6, 2021
    6:30 pm - 8:30 pm

Rare Genetic Diseases of Obesity:   Challenges and Patient Cases – Virtual Meeting Thursday, May 6, 2021 6:30 PM The disease education event will explain the role of the hypothalamic signaling pathway in appetite, energy and weight regulation.  The presentation will include how impairments in the melanocortin-4 receptor (MC4R) pathway may lead to insatiable hunger and Read moreMay 2021 – Rhythm Pharmaceuticals – DAPA – Rare Genetic Diseases of Obesity: Challenges and Patient Cases

AbbVie – Thursday, April 1st – Women’s Health – Oriahnn

We're sorry, but all tickets sales have ended because the event is expired.

  • April 1, 2021
    12:30 pm - 1:30 pm

AbbVie – Thursday, April 1st – Women’s Health – Oriahnn Dear DAPA members, The AbbVie Women’s Health Organization is pleased to connect with the community of Pharmacists in the Dallas area. We recognize your pharmacies provide services that cover a wide variety of medications, for diverse disease states, patient monitoring, and frequent communications with a Read moreAbbVie – Thursday, April 1st – Women’s Health – Oriahnn

AbbVie – Wednesday, March 31st – Women’s Health – Oriahnn

We're sorry, but all tickets sales have ended because the event is expired.

  • March 31, 2021
    6:00 pm - 7:00 pm

AbbVie – Wednesday, March 31st – Women’s Health Dear DAPA members, The AbbVie Women’s Health Organization is pleased to connect with the community of Pharmacists in the Dallas area. We recognize your pharmacies provide services that cover a wide variety of medications, for diverse disease states, patient monitoring, and frequent communications with a diversity of Read moreAbbVie – Wednesday, March 31st – Women’s Health – Oriahnn

April 2021 DAPA Meeting – AstraZeneca – Use of Dapagliflozin in Patients with Heart Failure with reduced Ejection Fraction (HFrEF)

We're sorry, but all tickets sales have ended because the event is expired.

  • April 8, 2021 - April 12, 2021
    6:30 pm

  You’re invited to join our April 2021 Meeting! Title Use of Dapagliflozin in Patients with Heart Failure with reduced Ejection Fraction (HFrEF) Presented by Jessica Hart, PharmD, BCACP – Medical Science Liaison, Cardiovascular and Metabolic – North Texas, Oklahoma, AstraZeneca When Thursday, April 8, 2021 at 6:30 PM This is a VIRTUAL meeting Are Read moreApril 2021 DAPA Meeting – AstraZeneca – Use of Dapagliflozin in Patients with Heart Failure with reduced Ejection Fraction (HFrEF)

March 2021 Prescribing and Monitoring Controlled Substances TSBP Required 1 Hr CE

We're sorry, but all tickets sales have ended because the event is expired.

  • March 4, 2021
    6:30 pm - 8:00 pm

Dallas Area Pharmacy Association and Texas Pharmacy Association Presents: An Overview of the Opioid Epidemic and Pharmacy’s Role in Addressing Prescription Drug Abuse Presented by:  Lisa D. Sullivan Drug Diversion – Safety Implication DEA Dallas Field Division When: THURSDAY, MARCH 4, 2021 AT 6:30 PM PLEASE READ: This Texas State Board of Pharmacy required Prescribing Read moreMarch 2021 Prescribing and Monitoring Controlled Substances TSBP Required 1 Hr CE

February 2021 DAPA Meeting is here! FREE TEXAS LAW CE FOR DAPA/TPA MEMBERS!

We're sorry, but all tickets sales have ended because the event is expired.

  • February 4, 2021
    6:30 pm - 8:30 pm

February 2021 DAPA Meeting is here! FREE TEXAS LAW CE FOR DAPA/TPA MEMBERS! Title: Texas State Board of Pharmacy Law Review and Updates Presented by: Allison Vordenbaumen Benz, R.Ph., M.S. Executive Director/Secretary Texas State Board of Pharmacy When: Thursday, February 4, 2021 at 6:30 PM This is a FREE Texas Law CE for DAPA/TPA members! PLEASE READ: This Read moreFebruary 2021 DAPA Meeting is here! FREE TEXAS LAW CE FOR DAPA/TPA MEMBERS!

DAPA November 2020 Meeting with Pfizer – Dermatology

We're sorry, but all tickets sales have ended because the event is expired.

  • November 5, 2020
    6:30 pm - 8:00 pm

DAPA November 2020 Meeting with Pfizer – Dermatology Topic: Pfizer Inflammation & Immunology Cross-Indication Pipeline Host: Kristine Bucasas Field Medical Director, Dermatology (TX, AR) Date: Thursday, November 5, 2020 Time: 6:30 pm, Central Time Register today! Everyone is welcome to the meeting. You will receive an email to join the meeting after you have registered and Read moreDAPA November 2020 Meeting with Pfizer – Dermatology

October DAPA Meeting with Astra Zeneca: Breztri Aerosphere Clinical Overview

We're sorry, but all tickets sales have ended because the event is expired.

  • October 1, 2020
    6:30 pm - 8:20 pm

October DAPA Meeting with Astra Zeneca: Breztri Aerosphere Clinical Overview You are invited to a AstraZeneca webinar to introduce an exciting new product in the respiratory world. When: Oct 1, 2020 06:30 PM Central Time (US and Canada) Topic: Breztri Aerosphere Clinical Overview & DAPA Meeting Speaker: Brian Meadors, PharmD, BCPS, BCPPS Medical Science Liaison Read moreOctober DAPA Meeting with Astra Zeneca: Breztri Aerosphere Clinical Overview